Madrigal Pharmaceuticals (MDGL) Insider Trading & Ownership → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free MDGL Stock Alerts $204.65 -13.73 (-6.29%) (As of 04/24/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Madrigal Pharmaceuticals (NASDAQ:MDGL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage23.92%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$43.38 MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$33.12 M Get MDGL Insider Trade Alerts Want to know when executives and insiders are buying or selling Madrigal Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MDGL Insider Buying and Selling by Quarter Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… Madrigal Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/8/2024Paul A FriedmanDirectorSell26,270$246.19$6,467,411.30 4/8/2024Rebecca TaubCMOSell2,676$245.99$658,269.24 4/5/2024Rebecca TaubCMOSell27,506$243.36$6,693,860.16 4/4/2024Paul A FriedmanDirectorSell18,710$242.96$4,545,781.60 4/3/2024Rebecca TaubCMOSell27,845$245.14$6,825,923.30 4/1/2024James M DalyDirectorSell32,489$102.77$3,338,894.53 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/1/2024Richard S LevyDirectorSell11,000$257.48$2,832,280.00 12/13/2023Bros. Advisors Lp BakerDirectorBuy81,159$219.39$17,805,473.01 12/13/2023Robert E WaltermireVPSell2,500$225.40$563,500.00 12/4/2023Brian Joseph LynchSVPSell1,800$218.87$393,966.00 11/29/2023Brian Joseph LynchSVPSell4,000$199.19$796,760.00 11/21/2023Bros. Advisors Lp BakerDirectorBuy64,350$188.47$12,128,044.50 11/17/2023Bros. Advisors Lp BakerDirectorBuy46,370$174.70$8,100,839.00 11/14/2023Bros. Advisors Lp BakerDirectorBuy34,188$156.42$5,347,686.96 (Data available from 1/1/2013 forward) MDGL Insider Trading Activity - Frequently Asked Questions Who is on Madrigal Pharmaceuticals's Insider Roster? The list of insiders at Madrigal Pharmaceuticals includes Brian Joseph Lynch, Bros. Advisors Lp Baker, James M Daly, Paul A Friedman, Rebecca Taub, Remy Sukhija, Richard S Levy, and Robert E Waltermire. Learn more on insiders at MDGL. What percentage of Madrigal Pharmaceuticals stock is owned by insiders? 23.92% of Madrigal Pharmaceuticals stock is owned by insiders. Learn more on MDGL's insider holdings. Which Madrigal Pharmaceuticals insiders have been buying company stock? The following insider purchased MDGL shares in the last 24 months: Bros. Advisors Lp Baker ($43,382,043.47). How much insider buying is happening at Madrigal Pharmaceuticals? Insiders have purchased a total of 226,067 MDGL shares in the last 24 months for a total of $43,382,043.47 bought. Which Madrigal Pharmaceuticals insiders have been selling company stock? The following insiders have sold MDGL shares in the last 24 months: Brian Joseph Lynch ($6,787,946.00), James M Daly ($3,338,894.53), Paul A Friedman ($11,013,192.90), Rebecca Taub ($14,178,052.70), Remy Sukhija ($8,224,200.00), Richard S Levy ($9,424,930.35), and Robert E Waltermire ($563,500.00). How much insider selling is happening at Madrigal Pharmaceuticals? Insiders have sold a total of 227,285 Madrigal Pharmaceuticals shares in the last 24 months for a total of $53,530,716.48 sold. More Insider Trading Tools from MarketBeat Related Companies: Alkermes Insider Buying Ionis Pharmaceuticals Insider Buying Amicus Therapeutics Insider Buying Rocket Pharmaceuticals Insider Buying Geron Insider Buying Dynavax Technologies Insider Buying Ligand Pharmaceuticals Insider Buying Ironwood Pharmaceuticals Insider Buying Y-mAbs Therapeutics Insider Buying Generation Bio Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:MDGL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
